“For people with OSA, using CPAP versus not using CPAP can literally be a matter of life or death,” said Carlos Nunez, M.D., Resmed’s Chief Medical Officer. “Decades of research have shown CPAP can ...

ResMed's fifth annual Global Sleep ... insights from 30,026 respondents across 13 markets, the study underscores a widespread global sleep crisis, with people losing an average of nearly three ...

studies, and, most recently, the results of a large new survey. The fifth annual Global Sleep Survey, from the health technology company ResMed, found from its more than 30,000 respondents around the ...

Resmed (RMD) announced the publication of a meta-analysis in The Lancet Respiratory Medicine, demonstrating that CPAP therapy significantly ...

(RTTNews) - Resmed Inc (RMD) Wednesday said it has published ... reduces the risk of death for people with obstructive sleep apnea (OSA). This meta analysis collected data from more than 1 million ...

SleepScore Labs CEO Colin Lawlor, as a 12-plus-year veteran in the sleep medical devices industry and someone who understands ...

A recent Global Sleep Survey from health technology company ResMed, meanwhile ... Still, some people do not like the idea, pointing to a study that showed couples who sleep physically close ...

The study, led by global experts in sleep and respiratory medicine and supported by Resmed, found that people with OSA who use CPAP therapy have: A 37% lower risk of dying from any cause compared ...

Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of dy ...

CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea, according to a landmark meta-analysis supported by Resmed and published in The Lancet Respiratory Medicine ...

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE ... Analyzing data from over 1 million sleep apnea patients worldwide, the study provides the strongest evidence to date that CPAP ...